• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌的手术考量

Surgical Considerations of Hilar Cholangiocarcinoma.

作者信息

Anderson Blaire, Doyle M B Majella

机构信息

Division of Transplantation Surgery, Department of Surgery, University of Nebraska Medical Center, 983285 Nebraska Medical Center, Omaha, NE 68198, USA.

Section of Abdominal Organ Transplant, Department of Surgery, Washington University School of Medicine, Washington University, 660 South Euclid Avenue, Campus Box 8109, St Louis, MO 63110, USA.

出版信息

Surg Oncol Clin N Am. 2019 Oct;28(4):601-617. doi: 10.1016/j.soc.2019.06.003. Epub 2019 Aug 2.

DOI:10.1016/j.soc.2019.06.003
PMID:31472908
Abstract

Cholangiocarcinoma is an aggressive malignancy of the extrahepatic bile ducts. Hilar lesions are most common. Patients present with obstructive jaundice and intrahepatic bile duct dilation. Cross-sectional imaging reveals local, regional, and distant extent of disease, with direct cholangiography providing tissue for diagnosis. The consensus of a multidisciplinary committee dictates treatment. Resection of the extrahepatic bile duct and ipsilateral hepatic lobe with or without vascular resection and transplantation after neoadjuvant protocol are options for curative treatment. The goal of surgery is to remove the tumor with negative margins. Patients with inoperable tumors or metastatic disease are best served with palliative chemoradiotherapy.

摘要

胆管癌是肝外胆管的侵袭性恶性肿瘤。肝门部病变最为常见。患者表现为梗阻性黄疸和肝内胆管扩张。横断面成像可显示疾病的局部、区域和远处范围,直接胆管造影可为诊断提供组织。多学科委员会的共识决定治疗方案。新辅助治疗方案后切除肝外胆管和同侧肝叶,可选择或不进行血管切除及移植,这是根治性治疗的选择。手术的目标是切除切缘阴性的肿瘤。对于无法手术切除的肿瘤或转移性疾病患者,最佳治疗方法是姑息性放化疗。

相似文献

1
Surgical Considerations of Hilar Cholangiocarcinoma.肝门部胆管癌的手术考量
Surg Oncol Clin N Am. 2019 Oct;28(4):601-617. doi: 10.1016/j.soc.2019.06.003. Epub 2019 Aug 2.
2
Hilar cholangiocarcinoma: expert consensus statement.肝门部胆管癌:专家共识声明
HPB (Oxford). 2015 Aug;17(8):691-9. doi: 10.1111/hpb.12450.
3
[Surgical therapy of hilar cholangiocarcinoma].[肝门部胆管癌的外科治疗]
Chirurg. 2006 Apr;77(4):325-34. doi: 10.1007/s00104-006-1177-4.
4
[Radical surgery for hilar cholangiocarcinoma (Klatskin tumor)].肝门部胆管癌(克氏瘤)的根治性手术
Cir Esp. 2007 Jul;82(1):11-5. doi: 10.1016/s0009-739x(07)71654-8.
5
Current therapy of hilar cholangiocarcinoma.肝门部胆管癌的当前治疗方法。
Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):12-7. doi: 10.1016/s1499-3872(11)60119-7.
6
Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.肝门部胆管癌根治性切除术后累及肝门的肝内胆管细胞癌的围手术期和长期预后:与周围型肝内胆管细胞癌和肝门部胆管癌的比较。
Surgery. 2018 May;163(5):1114-1120. doi: 10.1016/j.surg.2018.01.001. Epub 2018 Feb 2.
7
Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.肝门部胆管癌手术的进展显示预后改善:一项单中心分析
Tumori. 2014 Nov-Dec;100(6):e250-6. doi: 10.1700/1778.19288.
8
Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.单纯腹腔镜下肝门部胆管癌Ⅲa 型根治术。
Surg Endosc. 2018 Mar;32(3):1581-1582. doi: 10.1007/s00464-017-5741-4. Epub 2017 Aug 4.
9
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.采用肝切除或肝移植治疗肝门部胆管癌(克氏瘤)。
J Am Coll Surg. 1998 Oct;187(4):358-64. doi: 10.1016/s1072-7515(98)00207-5.
10
Robotic Resection of Type I Hilar Cholangiocarcinoma with Intrapancreatic Bile Duct Dissection.肝门部胆管癌Ⅰ型的机器人胰内胆管解剖切除术。
Ann Surg Oncol. 2022 Feb;29(2):964-969. doi: 10.1245/s10434-021-10811-7. Epub 2021 Oct 6.

引用本文的文献

1
"Hepatic hilum area priority, liver posterior first": An optimized strategy in laparoscopic resection for type III-IV hilar cholangiocarcinoma.“肝门区优先,肝后叶先行”:Ⅲ-Ⅳ型肝门部胆管癌腹腔镜切除术的优化策略
World J Gastrointest Surg. 2024 Jul 27;16(7):2167-2174. doi: 10.4240/wjgs.v16.i7.2167.
2
Application of mesohepatectomy with caudate lobectomy for the treatment of type III-IV hilar cholangiocarcinoma: a single-center retrospective study.应用中叶肝切除术联合尾叶切除术治疗 III-IV 型肝门部胆管癌:一项单中心回顾性研究。
Eur J Med Res. 2023 Jul 13;28(1):234. doi: 10.1186/s40001-023-01209-0.
3
Surgical management of hilar cholangiocarcinoma: Controversies and recommendations.
肝门部胆管癌的外科治疗:争议与建议。
Ann Hepatobiliary Pancreat Surg. 2023 Aug 31;27(3):227-240. doi: 10.14701/ahbps.23-028. Epub 2023 Jul 6.
4
Biliary drainage combined with simultaneous I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma.胆管引流联合 I 粒子链近距离放疗治疗肝门部胆管癌。
BMC Cancer. 2023 May 9;23(1):418. doi: 10.1186/s12885-023-10868-5.
5
Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection.血管侵犯和淋巴结转移介导了CA242对肝门部胆管癌患者根治性切除术后预后的影响。
Front Oncol. 2022 Dec 12;12:1071439. doi: 10.3389/fonc.2022.1071439. eCollection 2022.
6
Forkhead box M1 recruits FoxP3 Treg cells to induce immune escape in hilar cholangiocarcinoma.叉头框蛋白 M1 募集 FoxP3+Treg 细胞诱导肝门部胆管癌免疫逃逸。
Immun Inflamm Dis. 2022 Nov;10(11):e727. doi: 10.1002/iid3.727.
7
NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance.大鼠肝门部胆管癌中 NTCP 的变化及其治疗意义。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221109646. doi: 10.1177/15330338221109646.
8
FXR expression in rats of hilar cholangiocarcinoma.在大鼠肝门部胆管癌中 FXR 的表达。
Sci Rep. 2022 May 24;12(1):8741. doi: 10.1038/s41598-022-12850-w.
9
Preoperative Management of Perihilar Cholangiocarcinoma.肝门部胆管癌的术前管理
Cancers (Basel). 2022 Apr 24;14(9):2119. doi: 10.3390/cancers14092119.
10
Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.预测肝门部胆管癌术中不可切除性的模型:减少无效的手术探查。
PLoS One. 2022 Apr 13;17(4):e0258522. doi: 10.1371/journal.pone.0258522. eCollection 2022.